About
Kevin McBribe is a General Partner and Chief Scientific Officer at AmorChem Ventures and CEO at ARNA Therapeutics. He has held positions in academic research, biotech drug discovery and development, and business development, with experience working alongside venture capital investors. He has served as a science representative at the board level for multiple organizations.
Experience
- AmorChemGeneral Partner & CSOcurrent2023 — presentMontreal, Quebec, Canada
- AmorChemPartner & CSO2017 — 2022Westmount, Canada
- AmorChemVice President, Research2015 — 2017Montreal, Canada Area
- AmorChemDirector, Project Management2013 — 2015Montreal, Canada Area
- ARNA TherapeuticsCEOcurrent2021 — presentQuébec City, Quebec, Canada
- ARNA TherapeuticsMember Board Of Directorscurrent2020 — presentQuébec City, Quebec, Canada
- https://www.creativedestructionlab.com/Associate at Creative Destruction Lab - Torontocurrent2019 — presentToronto
- Mperia Therapeutics IncBoard Membercurrent2018 — presentMontreal
- Kodikaz Therapeutic Solutions, IncBoard Member2024 — 2025New York City
- Confidential Biotech CompanyScientific Consultant (Preclinical development program)2009 — 2012
- EnVivo Pharma (Boston)Scientific Consultant for development of novel CNS drug candidate2008 — 2009
- T2C2 CapitalScientific & Business Development Consultant2007 — 2008Montreal, Canada Area
- Chronogen Inc.Program Director2005 — 2008
- Chronogen Inc.Group Leader2003 — 2005
- Compatigene Inc.Scientific Director2001 — 2003
- IRCMSenior Investigator1996 — 2000
Education
- Queen's University BelfastM.Sc., Analytical Chemistry
- Queen's University BelfastB.Sc., Biochemistry
- School of Pharmacy, University of LondonPh.D., Biochemistry
Skills & more
Life Sciences9Biochemistry4Molecular Biology6Pharmacology5Biotechnology IndustryDrug Discovery6R&D4R&D Operations1Pre-clinical StudiesProject Management4Due Diligence4Web Content1
+12 more
Web DesignSocial MediaSocial Media MarketingInbound MarketingBloggerFacebook Fan Page CreationCross-functional Team LeadershipTeam LeadershipProtein ChemistryBiotechnologyLifesciencesBiopharmaceuticalsLanguages French
From Kevin's professional profile.
Same school
Also attended Queen's University Belfast26
Nessan BerminghamInvestor at Khosla VenturesJohnathan GrahamHead of Compliance at Fuel VenturesNicole StumpExecutive Assistant at Ensemble VCAndrew DryliePrincipal at Quadri VenturesJim CurranInvestment Director at Clarendon Fund Managers Ltd.Damien CallaghanChairman at Clarendon Fund Managers Ltd.
+ 20 more
